Impacto de tofacitinib en fatiga, sueño, y cualidad de vida relacionada con salud en pacientes con artritis reumatoide: un análisis post hoc de datos desde ensayos de fase 3
Arthritis Res Ther. 2022;24(1):83 doi:10.1186/s13075-022-02724-x
This was an exploratory post hoc analysis of pooled data, from over 2000 patients in three Phase 3 studies of tofacitinib, which demonstrates an association between tofacitinib treatment and significantly greater improvements in fatigue, sleep, and health-related quality of life (HRQoL), compared with placebo.